Leptin regulation of proopiomelanocortin

Frontiers of Hormone Research

Volumn 26, Issue , 1999, Pages 57-70

  Mobbs, Charles ^a   Mizuno, Tooru ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; BETA ENDORPHIN; HORMONE RECEPTOR; INTERMEDIN RECEPTOR; LEPTIN; MESSENGER RNA; PROOPIOMELANOCORTIN;

ANIMAL; DIET RESTRICTION; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; HYPOTHALAMUS; METABOLISM; OBESITY; PHYSIOLOGY; REVIEW;

ALPHA-MSH; ANIMALS; BETA-ENDORPHIN; FASTING; GENE EXPRESSION REGULATION; HUMANS; HYPOTHALAMUS; LEPTIN; OBESITY; PRO-OPIOMELANOCORTIN; RECEPTORS, PITUITARY HORMONE; RNA, MESSENGER;

EID: 0033656957     PISSN: 03013073     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000061015     Document Type: Article

References (57)

1. Bultman SJ, Michaud EJ, Woychik RP: Molecular characterization of the mouse agouti locus. Cell 1992;71:1195-1204.
2. Bultman SJ, Russell LB, Gutierrez-Espeleta GA, Woychik RP: Molecular characterization of a region of DNA associated with mutations at the agouti locus in the mouse. Proc Natl Acad Sci USA 1991;88:8062-8066.
3. Miller MW, DuhI DMJ, Vrieling H, Cordes SP, Ollmann MM, Winkes BM, Barsh GS: Cloning of the mouse agouti gene predicts a secrete protein ubiquitously expressed in mice carrying the lethal yellow mutation. Genes Dev 1993;7:454-467.
4. Hearing VJ, Tsukamoto K: Enyzmatic control of pigmentation in mammals. FASEB J 1991;5: 2902-2909.
5. Geschwind II: Change in hair color in mice induced by the injection of α-MSH. Endocrinology 1966;79:1165-1167.
6. Tamate HB, Takeuchi T: Action of the e locus of mice in the response of phaemelanic hair follicles to α melanocyte stimulating hormone in vitro. Science 1984;224:1241-1242.
7. Takeuchi T, Kobunai T, Yamamoto H: Genetic control of signal transduction in mouse melanocytes. J Invest Dermatol 1989;92:2395-2425.
8. Mountjoy KG, Robbins LS, Mortrud MT, Cone RD: The cloning of a family of genes that encode the melanocortin receptors. Science 1992;257:1248-1251.
9. Robbins LS, Nadeau JH, Johnson KR, Kelly MA, Roselli-Rehfuss L, Baack E, Mountjoy KG, Cone RG: Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell 1993;72:827-834.
10. Lu D, Willard D, Patel IR, Kadwell S, Overton L, Kost T, Luther M, Chen W, Woychik RP, Wilkison WO, Cone RD: Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature 1994;371:799-802.
11. Mountjoy KG, Mortrud MT, Low MJ, Simerly RB, Cone RD: Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 1994;8:1298-1308.
12. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F: Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997;88:131-141.
13. Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD: Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 1997;385:165-168.
14. Grandison L, Guidotti A: Stimulation of food intake by muscimol and beta endorphin. Neuropharmacology 1977;16:533-536.
15. Levine AS, Morley JE, Gosnell BA, Billington CJ, Bartness TJ: Opioids and consummatory behaviors. Brain Res Bull 1985;14:663-672.
16. Roberts JL, Seeburg PH, Shine J, Herbert E, Baxter JD, Goodman HM: Corticotropin and betaendorphin: Construction and analysis of recombinant DNA complementary to mRNA for the common precursor. Proc Natl Acad Sci USA 1979;76:2153-2157.
17. Gee CE, Chen CL, Roberts JL, Thompson R, Watson SJ: Identification of proopiomelanocortin neurones in rat hypothalamus by in situ cDNA-mRNA hybridization. Nature 1983;306:374-376.
18. Brady LS, Smith MA, Gold PW, Herkenham M: Altered expression of hypothalamic neuropeptide mRNAs in food-restricted and food-deprived rats. Neuroendocrinology 1990;52:441-447.
19. Bergendahl M, Wiemann JN, Clifton DK, Huhtaniemi I, Steiner RA: Short-term starvation decreases POMC mRNA but does not alter GnRH mRNA in the brain of adult male rats. Neuroendocrinology 1992;56:913-920.
20. Kim EM, Welch CC, Grace MK, Billington CJ, Levine AS: Chronic food restriction and acute food deprivation decrease mRNA levels of opioid peptides in arcuate nucleus. Am J Physiol 1996; 270:R1019-R1024.
21. Jhanwar-Uniyal M, Chua SC Jr: Critical effects of aging and nutritional state on hypothalamic neuropeptide Y and galanin gene expression in lean and genetically obese Zucker rats. Brain Res Mol Brain Res 1993;19:195-202.
22. Schwartz MW, Sipols AJ, Grubin CE, Baskin DG: Differential effect of fasting on hypothalamic expression of genes encoding neuropeptide Y, galanin, and glutamic acid decarboxylase. Brain Res Bull 1993;31:361-367.
23. Vergoni AV, Poggioli R, Bertonlini A: Corticotropin inhibits food intake in rats. Neuropeptides 1986;7:153-158.
24. Poggioli R, Vergoni AV, Bertolini A: ACTH-(1-24) and α-MSH antagonize feeding behavior stimulated by kappa opiate agonists. Peptides 1986;7:843-848.
25. Tsujii S, Bray GA: Acetylation alters the feeding response to MSH and b-endorphin. Brain Res Bull 1989;23:165-169.
26. Fong TM, Mao C, MacNeil T, Kalyani R, Smith T, Weinberg D, Tota MR, Van der Ploeg LH: ART (protein product of agouti-related transcript) as an antagonist of MC-3 and MC-4 receptors. Biochem Biophys Res Commun 1997;237:629-631.
27. Zhang Y, Proenca R, Maffe M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-432.
28. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM: Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995;269:543-546.
29. Mizuno TM, Bergen H, Funabashi T, Kleopoulos SP, Zhong YG, Bauman WA, Mobbs CV: Obese gene expression: Reduction by fasting and stimulation by insulin and glucose in lean mice, and persistent elevation in acquired (diet-induced) and genetic (yellow agouti) obesity. Proc Natl Acad Sci USA 1996;93:3434-3438.
30. Saladin R, De Vos P, Guerre-Millo M, Leturque A, Girard J, Staels B, Auwerx J: Transient increase in obese gene expression after food intake or insulin administration. Nature 1995;377:527-529.
31. Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, Flier JS: Role of leptin in the neuroendocrine response to fasting. Nature 1996;382:250-252.
32. Schwartz MW, Seeley RJ, Campfield CA, Burn P, Baskin DG: Identification of targets of leptin action in rat hypothalamus. J Clin Invest 1996;98:1101-1106.
33. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J, et al: Identification and expression cloning of a leptin receptor, OB-R. Cell 1995;83:1263-1271.
34. Lee GH, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG, Lee JI, Friedman JM: Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996;379:632-635.
35. Cheung CC, Clifton DK, Steiner RA: Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. Endocrinology 1997;138:4489-4492.
36. Thornton JE, Cheung CC, Clifton DK, Steiner RA: Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice. Endocrinology 1997;138:5063-5066.
37. Schwartz MW, Seeley RJ, Woods SC, Weigle DS, Campfield LA, Burn P, Baskin DG: Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes 1997;46:2119-2123.
38. Mizuno TM, Kleopoulos SP, Bergen HT, Roberts JL, Priest CA, Mobbs CV: Hypothalamic proopiomelanocortin mRNA is reduced by fasting in ob/ob and db/db mice, but is stimulated by leptin. Diabetes 1998;47:294-297.
39. Billington CJ, Briggs JE, Harker S, Grace M, Levine AS: Neuropeptide Y in hypothalamic paraventricular nucleus: A center coordinating energy metabolism. Am J Physiol 1994;266:R1765-R1770.
40. Levine As, Billington CJ: Why do we eat? A neural systems approach. Annu Rev Nutr 1997;17: 597-619.
41. Stephens TW, Basinski M, Bristow PK, Bue-Valleskey JM, Burgett SG, Craft L, Hale J, Hoffmann J, Hsiung HM, Kriauciunas A, Mackellar W, Rosteck PR Jr, Schoner B, Smith D, Tinsley FC, Zhang X-Y, Heiman M: The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 1995;377:530-532.
42. Schwartz MW, Baskin DG, Bukowski TR, Kuijper JL, Foster D, Lasser G, Prunkard DE, Porte D Jr, Woods SC, Seeley RJ, Weigle DS: Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 1996;45:531-535.
43. Erickson JC, Ahima RS, Hollopeter G, Flier JS, Palmiter RD: Endocrine function of neuropeptide Y knockout mice. Regul Pept 1997;70:199-202.
44. Erickson JC, Clegg KE, Palmiter RD: Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 1996;381:415-421.
45. Erickson JC, Hollopeter G, Palmiter RD: Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 1996;274:1704-1707.
46. Bergen H, Mizuno TM, Taylor J, Mobbs CV: Hyperphagia and weight gain after gold-thioglucose: Relation to hypothalamic neuropeptide Y and proopiomelanocorticotropin. Endocrinology 1998; 139:4483-4488.
47. Boston BA, Blaydon KM, Varnerin J, Cone RD: Independent and additive effects of central POMC and leptin pathways on murine obesity. Science 1997;278:1641-1644.
48. Seeley RJ, Yagaloff KA, Fisher SL, Burn P, Thiele TE, van Dijk G, Baskin DG, Schwartz MW: Melanocortin receptors in leptin effects (letter). Nature 1997;390:349.
49. Nagashima K, Zabriskie JB, Lyons MJ: Virus-induced obesity in mice: Association with a hypothalamic lesion. J Neuropathol Exp Neurol 1992;51:101-109.
50. Good DJ, Porter FD, Mahon KA, Parlow AF, Westphal H, Kirsch IR: Hypogonadism and obesity in mice with a targeted deletion of the Nhlh2 gene. Nat Genet 1997;15:397-401.
51. Lloyd JM, Scarbrough K, Weiland NG, Wise PM: Age-related changes in proopiomelanocortin (POMC) gene expression in the periarcuate region of ovariectomized rats. Endocrinology 1991;129: 1896-1902.
52. Naggert JK, Fricker LD, Varlamov O, Nishina PM, Rouille Y, Steiner DF, Carroll RJ, Paigen BJ, Leiter EH: Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity. Nat Genet 1995;10:135-142.
53. Cool DR, Normant E, Shen F, Chen HC, Pannell L, Zhang Y, Loh YP: Carboxypeptidase E is a regulated secretory pathway sorting receptor: Genetic obliteration leads to endocrine disorders in Cpe(fat) mice. Cell 1997;88:73-83.
54. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sewter CP, Digby JE, Mohammed SN, Hurst JA, Cheetham CH, Earley AR, Barnett AH, Prins JB, O'Rahilly S: Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997;387:903-908.
55. Clement K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, Gourmelen M, Dina C, Chambaz J, Lacorte JM, Basdevant A, Bougneres P, Lebouc Y, Froguel P, Guy-Grand B: A mutation in the human leptin receptor gene causes obesity and pituitary dystunction. Nature 1998;392:398-401.
56. Jackson RS, Creemers JWM, Ohagi S, Raffin-Sanson ML, Sanders L, Montague CT, Hutton JO, O'Rahilly S: Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat Genet 1997;16:303-306.
57. Krude H, Biebermann H, Luck W, Horn R, Brabant G, Gruters A: Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 1997;19:155-157.